# Samyang Biopharm inaugurates EUR 26.2 million plant in Gödöllő, Hungary

Samyang Biopharm has inaugurated a new EUR 26.2 million plant in Gödöllő, Hungary, for manufacturing synthetic suture materials. The facility will create 55 jobs and production is expected to increase from 30,000 km/year to 100,000 km/year.

- Type: New facility
- Announced: 2023-06-14
- Where: Gödöllő, Hungary
- Value: $28.5M (26.2M EUR)
- Jobs: 55
- Starts operating: 14 Jun 2023
- Status: completed
- Capacity: 30,000 km/year (initial), 100,000 km/year (projected)
- Products: synthetic suture materials
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Samyang Biopharm](https://endata.com/companies/48970.md)

## Sources

- [dteurope.com](https://dteurope.com/business/new-samyang-biopharm-plant-in-godollo/), 2023-06-14: "Korean-owned Samyang Biopharm’s new plant built for EUR 26.2 million has been inaugurated in Gödöllő where synthetic suture materials are manufactured."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.